JO3525B1 - Treatment of metastatic stage prostate cancer with degarelix - Google Patents
Treatment of metastatic stage prostate cancer with degarelixInfo
- Publication number
- JO3525B1 JO3525B1 JOP/2009/0062A JOP20090062A JO3525B1 JO 3525 B1 JO3525 B1 JO 3525B1 JO P20090062 A JOP20090062 A JO P20090062A JO 3525 B1 JO3525 B1 JO 3525B1
- Authority
- JO
- Jordan
- Prior art keywords
- degarelix
- treatment
- prostate cancer
- stage prostate
- metastatic stage
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Compositions comprising degarelix for the treatment of metastatic stage prostate cancer in a subject are provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2774108P | 2008-02-11 | 2008-02-11 | |
EP08250703 | 2008-02-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3525B1 true JO3525B1 (en) | 2020-07-05 |
Family
ID=69095472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2009/0062A JO3525B1 (en) | 2008-02-11 | 2009-02-09 | Treatment of metastatic stage prostate cancer with degarelix |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP7104003B2 (en) |
HK (1) | HK1258957A1 (en) |
JO (1) | JO3525B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20090061B1 (en) * | 2008-02-11 | 2021-08-17 | Ferring Int Center Sa | METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST |
-
2009
- 2009-02-09 JO JOP/2009/0062A patent/JO3525B1/en active
-
2019
- 2019-01-28 HK HK19101439.6A patent/HK1258957A1/en unknown
- 2019-08-01 JP JP2019142260A patent/JP7104003B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2019218360A (en) | 2019-12-26 |
HK1258957A1 (en) | 2019-11-22 |
JP7104003B2 (en) | 2022-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010008817A (en) | Treatment of metastatic stage prostate cancer with degarelix. | |
IN2012DN02046A (en) | ||
SI2358697T1 (en) | Isoindoline compounds for use in the treatment of cancer. | |
EP2197533A4 (en) | Prostate cancer ablation | |
JO2788B1 (en) | Amidophenoxyindazoles useful as inhibitors of c-met | |
ZA201102362B (en) | Molecular markers in prostate cancer | |
EP2135600A4 (en) | Targeting agent for cancer cell or cancer-associated fibroblast | |
EP2200431A4 (en) | Novel compositions and methods for cancer treatment | |
MX2010000465A (en) | Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders. | |
EP2310006A4 (en) | Treating cancer | |
MX2011011431A (en) | Composition for the treatment of prostate cancer. | |
MY146112A (en) | Long-term feed - cancer patient | |
IL186980A0 (en) | Characterizing prostate cancer | |
EP2300040A4 (en) | Methods and compositions for prostate cancer immunotherapy | |
GB0804496D0 (en) | Treating cancer | |
EP2374463A4 (en) | Composition for improving radiotherapy for cancer | |
EP2137213A4 (en) | Methods and compositions for treating prostate cancer | |
JO3525B1 (en) | Treatment of metastatic stage prostate cancer with degarelix | |
GB0809046D0 (en) | Cancer treatment | |
WO2009097095A9 (en) | Methods for treating hematopoietic malignancies | |
WO2010002454A3 (en) | Therapeutic combinations for use in neoplasia | |
AU323022S (en) | Birdcage roof | |
GB0818566D0 (en) | Improvements in the chemotherapy of cancer | |
GB0809730D0 (en) | Improvements in the chemotherapy of cancer | |
JO3550B1 (en) | Composition for the Treatment of Prostate Cancer |